Tissue-engineered vascular graft remodeling in a growing lamb model: Expression of matrix metalloproteinases

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 1, 2012, Pages 167-172

  Cummings, Ian ^a,b   George, Sarah ^c   Kelm, Jens ^a,b   Schmidt, Doerthe ^a,b   Emmert, Maximilian Y ^a,b   Weber, Benedikt ^a,b   Zünd, Gregor ^a,b   Hoerstrup, Simon P ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Autologous; Cells; Growth; Matrix metalloproteinases; Tissue engineering; Vascular graft

Indexed keywords

BUTYRIC ACID; COLLAGEN; GELATINASE A; GELATINASE B; POLY 4 HYDROXYBUTYRATE; POLYGLYCOLIC ACID; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; BIODEGRADABILITY; BLOOD VESSEL GRAFT; FOLLOW UP; IN VITRO STUDY; LAMB; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; TISSUE CULTURE; TISSUE ENGINEERING; UPREGULATION; ZYMOGRAPHY; ANIMAL; BIODEGRADABLE IMPLANT; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; DISEASE MODEL; ENZYMOLOGY; METABOLISM; METHODOLOGY; PATHOLOGY; SHEEP; TISSUE CULTURE TECHNIQUE;

ABSORBABLE IMPLANTS; ANIMALS; BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COLLAGEN; DISEASE MODELS, ANIMAL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; PULMONARY ARTERY; SHEEP; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84860317061     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.02.077     Document Type: Article

References (25)

1. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science 1999;284:489-93.
2. Poh M, Boyer M, Solan A, Dahl SL, Pedrotty D, Banik SS, McKee JA, Klinger RY, Counter CM, Niklason LE. Blood vessels engineered from human cells. Lancet 2005;365:2122-4.
3. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005;129:1330-8.
4. Hoerstrup SP, Cummings Mrcs I, Lachat M, Schoen FJ, Jenni R, Leschka S, Neuenschwander S, Schmidt D, Mol A, Gunter C, Gossi M, Genoni M, Zund G. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 2006;114:I159-66.
5. Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 1962;48:1014-22.
6. Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 1990;87:5578-82.
7. Merchant SJ, Davidge ST. The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and pre-eclampsia. BJOG 2004;111:931-9.
8. Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C, Tedgui A, Dussaule JC, Lehoux S. Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension 2007;50:212-8.
9. Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 2005;39: 457-64.
10. Zaltsman AB, Newby AC. Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity. Atherosclerosis 1997;130:61-70.
11. Zempo N, Kenagy RD, Au YP, Bendeck M, Clowes MM, Reidy MA, Clowes AW. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg 1994;20:209-17.
12. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994;75:539-45.
13. Southgate KM, Davies M, Booth RF, Newby AC. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J 1992;288:93-9.
14. George SJ, Zaltsman AB, Newby AC. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. Cardiovasc Res 1997;33:447-59.
15. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516.
16. Whatling C, McPheat W, Hurt-Camejo E. Matrix management: assigning different roles for MMP-2 and MMP-9 in vascular remodeling. Arterioscler Thromb Vasc Biol 2004;24:10-11.
17. Stock UA, Wiederschain D, Kilroy SM, Shum-Tim D, Khalil PN, Vacanti JP, Mayer JE Jr., Moses MA. Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures. J Cell Biochem 2001;81:220-8.
18. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE Jr. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102:III44-9.
19. Huszar G, Maiocco J, Naftolin F. Monitoring of collagen and collagen fragments in chromatography of protein mixtures. Anal Biochem 1980; 105:424-9.
20. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986;231:397-400.
21. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6.
22. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006;12:361-5.
23. Lancelot E, Amirbekian V, Brigger I, Raynaud JS, Ballet S, David C, Rousseaux O, Le Greneur S, Port M, Lijnen HR, Bruneval P, Michel JB, Ouimet T, Roques B, Amirbekian S, Hyafil F, Vucic E, Aguinaldo JG, Corot CFayad ZA. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol 2008;28:425-32.
24. Zilla P, Bezuidenhout D, Human P. Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials 2007;28:5009-27.
25. Rubbens MP, Driessen-Mol A, Boerboom RA, Koppert MM, van Assen HC, TerHaar Romeny BM, Baaijens FP, Bouten CV. Quantification of the temporal evolution of collagen orientation in mechanically conditioned engineered cardiovascular tissues. Ann Biomed Eng 2009; 37:1263-72.